BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30753527)

  • 1. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
    Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
    Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.
    Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X
    Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications.
    Iannielli A; Luoni M; Giannelli SG; Ferese R; Ordazzo G; Fossati M; Raimondi A; Opazo F; Corti O; Prehn JHM; Gambardella S; Melki R; Broccoli V
    Cell Death Dis; 2022 Oct; 13(10):881. PubMed ID: 36261424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.
    Akrioti E; Karamitros T; Gkaravelas P; Kouroupi G; Matsas R; Taoufik E
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single cell high content assay detects mitochondrial dysfunction in iPSC-derived neurons with mutations in SNCA.
    Little D; Luft C; Mosaku O; Lorvellec M; Yao Z; Paillusson S; Kriston-Vizi J; Gandhi S; Abramov AY; Ketteler R; Devine MJ; Gissen P
    Sci Rep; 2018 Jun; 8(1):9033. PubMed ID: 29899557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
    Lee SY; Jeong S; Kim J; Chung SK
    Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Parkinson's disease using induced pluripotent stem cells.
    Byers B; Lee HL; Reijo Pera R
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Buoso C; Seifert M; Lang M; Griffith CM; Talavera Andújar B; Castelo Rueda MP; Fischer C; Doerrier C; Talasz H; Zanon A; Pramstaller PP; Schymanski EL; Pichler I; Weiss G
    Neurobiol Dis; 2024 Jun; 196():106506. PubMed ID: 38648865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells.
    Oliveira LM; Falomir-Lockhart LJ; Botelho MG; Lin KH; Wales P; Koch JC; Gerhardt E; Taschenberger H; Outeiro TF; Lingor P; Schüle B; Arndt-Jovin DJ; Jovin TM
    Cell Death Dis; 2015 Nov; 6(11):e1994. PubMed ID: 26610207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification.
    Vuidel A; Cousin L; Weykopf B; Haupt S; Hanifehlou Z; Wiest-Daesslé N; Segschneider M; Lee J; Kwon YJ; Peitz M; Ogier A; Brino L; Brüstle O; Sommer P; Wilbertz JH
    Stem Cell Reports; 2022 Oct; 17(10):2349-2364. PubMed ID: 36179692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
    Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
    Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
    Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
    Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
    Byers B; Cord B; Nguyen HN; Schüle B; Fenno L; Lee PC; Deisseroth K; Langston JW; Pera RR; Palmer TD
    PLoS One; 2011; 6(11):e26159. PubMed ID: 22110584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.
    Pathak D; Berthet A; Bendor JT; Yu K; Sellnow RC; Orr AL; Nguyen MK; Edwards RH; Manfredsson FP; Nakamura K
    eNeuro; 2017; 4(2):. PubMed ID: 28462393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.